COMP <GO>
CHCI vs BAC // EV/EBITDA & P/E VALUATION
Comstock Holding Companies Inc. (Class A) (NASDAQ) VS. Bank of America Corporation (NYSE) • 15-METRIC TALLY: CHCI 7
— BAC 3
▲ EV/EBITDA & P/E VALUATION LEADER: CHCI
LAST: $17.96 (-3.85%) • MKT CAP: $192.1M
valuation
13.5x
LAST: $50.01 (-2.21%) • MKT CAP: $357.61B
valuation
30.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CHCI VS. BAC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CHCI | BAC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 24.40% | 2.50% | +21.90 | CHCI | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 13.5x | 30.2x | -16.70 | CHCI | /valuation <GO> |
| Free Cash Flow Yield | 2.50% | 2.10% | +0.40 | CHCI | /fcf-yield <GO> |
| Operating Margin | 19.00% | 32.90% | -13.90 | BAC | /operating-margins <GO> |
| Net Profit Margin | 27.10% | 27.00% | +0.10 | CHCI | /net-margins <GO> |
| Revenue Growth (YoY) | 22.60% | 6.80% | +15.80 | CHCI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | BAC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.0 | 38.3 | +8.73 | CHCI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.90 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 9.5x | 10.9x | -1.40 | CHCI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $192.1M | $357.61B | -$357.42B | BAC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CHCI REV | BAC REV | CHCI GROSS % | BAC GROSS % | CHCI FCF | BAC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $62.9M | $113.10B | — | — | $4.8M | $7.52B |
| FY 2024 | $51.3M | $105.86B | — | — | $10.7M | -$13.57B |
| FY 2023 | $44.7M | $102.77B | — | — | $9.0M | $40.36B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CHCI // BETA —
BAC // BETA 0.90